• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.

作者信息

Hubbard R C, McElvaney N G, Birrer P, Shak S, Robinson W W, Jolley C, Wu M, Chernick M S, Crystal R G

机构信息

Pulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, Md. 20892.

出版信息

N Engl J Med. 1992 Mar 19;326(12):812-5. doi: 10.1056/NEJM199203193261207.

DOI:10.1056/NEJM199203193261207
PMID:1538726
Abstract
摘要

相似文献

1
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
N Engl J Med. 1992 Mar 19;326(12):812-5. doi: 10.1056/NEJM199203193261207.
2
Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther. 1994 Apr 15;36(920):34-5.
3
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.雾化重组人脱氧核糖核酸酶对囊性纤维化患者呼吸道症状加重及肺功能的影响。Pulmozyme研究组。
N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003.
4
Where we are now with rhDNase.我们目前在重组人脱氧核糖核酸酶方面的进展。
Lancet. 1999 May 22;353(9166):1727. doi: 10.1016/S0140-6736(98)00411-5.
5
Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.重组人脱氧核糖核酸酶对囊性纤维化患者肺功能长期影响的统计分析
J Biopharm Stat. 2000 Aug;10(3):287-97. doi: 10.1081/BIP-100102495.
6
Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.雾化重组人脱氧核糖核酸酶I治疗囊性纤维化
N Engl J Med. 1992 Aug 20;327(8):571. doi: 10.1056/NEJM199208203270820.
7
New treatment for cystic fibrosis.
Am Pharm. 1994 Feb;NS34(2):16-8.
8
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.一项针对轻度肺功能异常的囊性纤维化年轻患者的为期两年的多纳酶α随机安慰剂对照试验。
J Pediatr. 2001 Dec;139(6):813-20. doi: 10.1067/mpd.2001.118570.
9
Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.重组人脱氧核糖核酸酶对囊性纤维化患者气流阻塞和黏液纤毛清除功能的影响。
Am J Respir Crit Care Med. 1996 Feb;153(2):752-60. doi: 10.1164/ajrccm.153.2.8564129.
10
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.雾化吸入重组人脱氧核糖核酸酶I短期治疗稳定期成人囊性纤维化的疗效和安全性。
Lancet. 1993 Jul 24;342(8865):199-202. doi: 10.1016/0140-6736(93)92297-7.

引用本文的文献

1
Efficacy of Adding Oral N acetyl Cysteine Supplement to the Cystic Fibrosis Treatment Regimen: A Randomized Quasi-Experimental Trial.在囊性纤维化治疗方案中添加口服N-乙酰半胱氨酸补充剂的疗效：一项随机准实验性试验。
J Res Pharm Pract. 2025 Mar 11;13(3):72-77. doi: 10.4103/jrpp.jrpp_54_24. eCollection 2024 Jul-Sep.
2
Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association).巴西囊性纤维化肺部症状药物治疗指南。巴西胸科学会（SBPT）官方文件。
J Bras Pneumol. 2023 May 15;49(2):e20230040. doi: 10.36416/1806-3756/e20230040. eCollection 2023.
3
Insights into Personalised Medicine in Bronchiectasis.
支气管扩张症个性化医疗的见解
J Pers Med. 2023 Jan 10;13(1):133. doi: 10.3390/jpm13010133.
4
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer.使用台式流变仪对气道黏液进行快速粘弹性表征
J Vis Exp. 2022 Apr 21(182). doi: 10.3791/63876.
5
Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics.生物分析方法与战略视角：应对新型生物缀合物和生物治疗药物传递途径日益增加的复杂性。
BioDrugs. 2022 Mar;36(2):181-196. doi: 10.1007/s40259-022-00518-w. Epub 2022 Apr 1.
6
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100)).比较生物仿制药 Tigerase 和 Pulmozyme 在囊性纤维化和严重肺损伤患者的长期症状治疗中的效果（III 期随机开放标签临床试验（NCT04468100）的亚组分析）。
PLoS One. 2021 Dec 23;16(12):e0261410. doi: 10.1371/journal.pone.0261410. eCollection 2021.
7
Dornase alfa for cystic fibrosis.阿法链道酶（Dornase alfa）治疗囊性纤维化。
Cochrane Database Syst Rev. 2021 Mar 18;3(3):CD001127. doi: 10.1002/14651858.CD001127.pub5.
8
Timing of dornase alfa inhalation for cystic fibrosis.吸入用胰蛋白酶原治疗囊性纤维化的时机。
Cochrane Database Syst Rev. 2021 Mar 9;3(3):CD007923. doi: 10.1002/14651858.CD007923.pub6.
9
Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.气道氧化还原稳态与炎症失调：从分子发病机制到呼吸病理学中的新兴治疗策略。
Int J Mol Sci. 2020 Dec 7;21(23):9317. doi: 10.3390/ijms21239317.
10
Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers.喷射式和网状雾化器产生的重组人脱氧核糖核酸酶α的雾化给药
Pharmaceutics. 2020 Jul 31;12(8):721. doi: 10.3390/pharmaceutics12080721.